Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1989-8-25
|
| pubmed:abstractText |
To investigate the hypothesis that endurance exercise may lead to a decrease in ventilatory chemosensitivity as possibly mediated by an increase in endogenous beta-endorphins, we measured hypercapnic ventilatory responsiveness (HCVR) and circulating beta-endorphin immunoreactivity in six runners before and after a marathon (42.2 km) race and after administration of 10 mg iv naloxone. Similar testing was performed at identical time periods on the day before the marathon as control data. On each occasion, HCVR was measured twice 15 min apart, and the mean value was used for analysis. Six active (training distance 50-104 km/wk) and experienced (no. of marathons completed, 1-25) runners participated in the study. There were no significant changes in beta-endorphin activity or HCVR on the control day. All runners experienced a rise in beta-endorphin activity from premarathon (21.3 +/- 16.0 pg/ml) to immediate postmarathon (89.6 +/- 84.9 pg/ml) values (P less than 0.05). However, HCVR showed no significant change at any of the three testing periods on the marathon day. To investigate whether a time delay may have affected the lack of response to naloxone, additional testing was performed in five subjects, except that 10 mg iv naloxone was given within 10 min after completion of the marathon, and then HCVR was measured. Although there was a greater than fourfold increase in beta-endorphin immunoreactivity after the marathon, there was no significant change in HCVR after naloxone administration. We conclude that natural increases in endogenous beta-endorphin activity associated with marathon running do not modulate central chemosensitivity.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
8750-7587
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
66
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2431-6
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:2526117-Adult,
pubmed-meshheading:2526117-Carbon Dioxide,
pubmed-meshheading:2526117-Female,
pubmed-meshheading:2526117-Forced Expiratory Volume,
pubmed-meshheading:2526117-Humans,
pubmed-meshheading:2526117-Lung,
pubmed-meshheading:2526117-Male,
pubmed-meshheading:2526117-Oxygen Consumption,
pubmed-meshheading:2526117-Physical Exertion,
pubmed-meshheading:2526117-Reference Values,
pubmed-meshheading:2526117-Respiration,
pubmed-meshheading:2526117-Running,
pubmed-meshheading:2526117-Vital Capacity,
pubmed-meshheading:2526117-beta-Endorphin
|
| pubmed:year |
1989
|
| pubmed:articleTitle |
Beta-endorphin activity and hypercapnic ventilatory responsiveness after marathon running.
|
| pubmed:affiliation |
Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire 03576.
|
| pubmed:publicationType |
Journal Article
|